A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the effectiveness and safety of the
propionyl-L-carnitine hydrochloride tablets among Chinese population in comparison with the
placebo, for treatment of the peripheral arterial diseases (intermittent claudication) with
oral supplementation of 2g daily for a 4 months continuous administration.